Shilpa Medicare’s Plan For Eylea Biosimilar Spells Ambition, But Path Not Easy

Humira Biosimilar Trial Recruiting

 
• By Vibha Ravi
Arrow being aimed at man flying with arrow in hand
Shilpa's Biosimilars Ambitions Could Face Obstacles • Source: Alamy

More from R&D

More from Scrip